Latest News

Bluechiip Raises $5.5M and announces share purchase plan

11 September 2018

Download the full announcement here: https://www.asx.com.au/asxpdf/20180910/pdf/43y5vwqsg73qxh.pdf   BLUECHIIP RAISES $5.5 MILLION AND ANNOUNCES SHARE PURCHASE PLAN   Bluechiip Limited (Bluechiip or the Company, ASX: BCT), a leader in the development of sample-tracking technology for harsh environments, today announced it has successfully raised $5.5 million via an oversubscribed placement to sophisticated and professional investors. The placement comprised…

Discover More >

Open Briefing interview with MD Andrew McLellan

01 September 2018

Download the ASX announcement here: https://www.asx.com.au/asx/statistics/displayAnnouncement.do?display=pdf&idsId=02017004   In this Open Briefing®, Andrew discusses: ·                     A$15.9m, three-year deal with Labcon North America ·                     Expectation for margins and NPAT and operating cash flow positive from this one contract ·                     Ramp up of production and consideration of working capital sources ·                     Adjacent markets beyond this Labcon order that can…

Discover More >

Bluechiip signs three-year $A15M supply deal with Labcon

29 August 2018

Bluechiip signs three-year $A15M supply deal with Labcon Highlights:  New three-year deal added to existing Labcon North America Development and Supply Agreement $US4.2m ($A5.8m) two-year purchase order for Chips, readers, software and engineering services $US7.4m ($A10.1m) agreed minimum for third year See full announcement here: https://www.asx.com.au/asxpdf/20180829/pdf/43xt21br9gcvjd.pdf Bluechiip Limited [ASX: BCT] a leader in the development of…

Discover More >

Open Briefing interview with MD Andrew McLellan

02 July 2018

Open Briefing interview with MD Andrew McLellan In this Open Briefing®, Andrew discusses: • Accelerating chip deliveries and resultant revenues • Receipt of multi-vial chip reader product and for new orders • Attendance at industry trade shows • Rising R & D tax credits, linked to rising production and expenditure Record of interview: Andrew, can…

Discover More >

Finnance News Network Bluechiip Presentation and Interview, FNN Investor Event, May 2018, Sydney

10 May 2018

BlueChiip Limited (ASX:BCT) Managing Director, Andrew McLellan presents an update on the company’s MEMS (micro-electro-mechanical) based tracking tags, range of applications and sales. Unique Micro-Electro Mechanical Systems (MEMS) micro device, superior to labels, barcodes and RFID 25 granted patents and 5 patent applications Individual ID extremely difficult to copy Instant sample temperature sensing Rapid read time, even…

Discover More >

CommSec Executive Series Interview

24 April 2018

Andrew McLellan, Bluechiip Limited Managing Director, was recently interviewed as part of the CommSec Executive Series. In the interview, Andrew McLellan explains the Company’s technology, progress with Original Equipment Manufacturers (OEMs) and other recent activities. A video recording of the interview can be found here: https://www.bluechiip.com/investor/company-overview/ The original ASX announcement can be found here: https://www.asx.com.au/asxpdf/20180424/pdf/43tg365ccmlj2h.pdf

Discover More >

Bluechiip Corporate Overview and March 2018 Update

14 March 2018

Please find in the link below Bluechiip corporate overview and March 2018 corporate update https://www.asx.com.au/asxpdf/20180314/pdf/43sdwbsfnwfkgv.pdf Highlights: • Dramatically increasing partner pipeline, 21 developer kits sold up from 16 last quarter • Highly differentiated, expanding, protected IP portfolio • Large growing target market with very large adjacent markets • Well advanced product development entering manufacture •…

Discover More >

Managing Director, Andrew McLellan on 1H FY18 results and outlook

26 February 2018

In this Open Briefing®, Andrew discusses: Bluechiip progression from being in development into a manufacturing company Accelerating production volumes and revenue generation Receipt of a $776k R & D tax refund in January, with more to come and current $2m cash balance Labcon $1m order status and marketing a range of vials incorporating Bluechiip technology…

Discover More >